# An Observational Study on Predictive Factors of Response in Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Ribavirin

> **NCT01392742** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 443 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01392742
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05-31
- **Primary completion:** 2014-07-31
- **Final completion:** 2014-07-31
- **Target enrollment:** 443 (ACTUAL)
- **Last updated:** 2017-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01392742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01392742, "An Observational Study on Predictive Factors of Response in Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Ribavirin". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01392742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*